NovaBridge Biosciences's total assets for Q3 2025 were ¥277.41M, an increase of 34.20% from the previous quarter. NBP total liabilities were ¥18.50M for the fiscal quarter, a 85.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.